Department of Defense - NavyMarch 4, 2026

FDA 483 - Department of Defense - Navy - March 04, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Department of Defense - Navy

Record Details

An FDA inspection of the Department of Defense - Navy's Hospital Blood Bank in Agana Heights, GU, revealed a significant failure in donor screening procedures. The firm did not consistently obtain confirmation from donors regarding their postal address for 8 weeks post-donation, a critical requirement for donor traceability. This issue was observed during donor screenings and was also noted as a deficiency in the firm's standard operating procedures.

Company: Department of Defense - Navy
Inspection Date: March 4, 2026
Product Type: Biologics
Office: Division of Human and Animal Food Operations - West VI
Person: Maurine Fadlalla (FDA_PERSONNEL)

Open in Dashboard

ID · 879fed92-7024-42d0-ad39-81eddbbbc791